Detalles de la búsqueda
1.
Screening and monitoring of the BTKC481S mutation in a real-world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy.
Br J Haematol
; 194(2): 355-364, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34019713
2.
Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.
J Pathol Clin Res
; 10(1): e351, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37987115
3.
Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax.
Pathology
; 54(1): 95-103, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34332791
Resultados
1 -
3
de 3
1
Próxima >
>>